This database is populated with information on the results of Roche-sponsored clinical trials.
Product Name: Ixel [milnacipran] Date of Report: 12/1/2005 Phase: IV Open study to evaluate the efficacy and safety of milnacipran in outpatients experiencing major depression and non-responders to SSRI therapy.